Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients

Cancer Research

Volumn 48, Issue 11, 1988, Pages 3140-3147

  McLemore, Theodore L ^a   Hubbard, Walter C ^a   Litterst, Charles L ^a   Liu, Mark C ^a   Miller, Stephan ^a   McMahon, Noreen A ^a   Eggleston, Joseph ^a   Boyd, Michael R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ARTICLE; HUMAN; HUMAN CELL; LUNG CANCER; NORMAL VALUE; PROSTAGLANDIN SYNTHESIS;

ARACHIDONIC ACID; ARACHIDONIC ACIDS; CARCINOMA; COMPARATIVE STUDY; FEMALE; HUMAN; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEOPLASM METASTASIS; PROSTAGLANDINS; SMOKING;

EID: 0023952352     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Silverberg, E. Cancer Statistics, 1985. CA Cancer J. Clin., 35:19-35, 1985.
2. Horn, J. W., Asire, A. J., Young, J. L., and Pollack, E. S. SEER Program: Cancer Incidence and Mortality in the United States 1973–1981. NIH Publication No. 85–1837. Bethesda, MD: Department of Health and Human Services, 1984.
3. Loeb, L. A., Ernster, V. L., Warner, K. E., Abbotts, J., and Laszlo, J. L. Smoking and lung cancer an overview. Cancer Res., 44:5940-5958,1984.
4. American Cancer Society. 1986 Facts and Figures, pp. 1–32. New York: American Cancer Society, 1986.
5. Minna, J. D., Ihde, D. C., and Glatstein, E. J. Lung cancer scalpels, beams, drugs and probes. N. Engl. J. Med., 315:1411-1413,1986.
6. Yesner, R. Spectrum of lung cancer and ectopic hormones. Pathol. Annu., 13 (Part IV 217-240,1978.
7. Yesner, R., and Carter, D. Pathology of carcinoma of the lung: changing patterns. Clin. Chest Med., 3:257-289,1982.
8. Mathews, M. J., and Gazdar, A. F. Pathology of small cell carcinomas of the lung and its subtypes. A clinico-pathologic correlation. In: R. Livingston (ed.), Lung Cancer, Vol. 1, pp. 283–307. The Hague: Martinus Nijhoff, 1981.
9. Gazdar, A. F., Carney, D. N., Nau, M. M., and Minna, J. D. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res., 45:2924-2930,1985.
10. Hyman, A. L., Spannhake, E. W., and Kadowitz, P. J. State of the art: prostaglandins and the lung. Am. Rev. Respir. Dis., 117:111-136, 1978.
11. Newman, J. M., and Shelter, J. R. Review: arachidonic acid metabolites in the healthy and diseased lung. Am. J. Med. Sci., 288:75-80,1984.
12. Mathe, A. A., Hedqvist, P., Strandberg, I. F., and Leslie, C. A. Aspects of prostaglandin function in the lung (two parts). N. Engl. J. Med., 296: 850-855,910-914,1977.
13. Seyberth, H. W., Segre, G. V., Morgan, J. L., Sweetman, B. J., Potts, Jr. J. T., and Oates, J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N. Engl. J. Med., 293:1278-1283, 1975.
14. Bennett, A., Carroll, M. A., Stamford, I. F., Whimster, W. F., and Williams, F. Prostaglandins and human lung carcinomas. Br. J. Cancer, 46:888-893, 1982.
15. Lau, S. S., McMahon, J. B., McMenamin, M. G., Schuller, H. M., and Boyd, M. R. Differential metabolism of arachidonic acid in human lung carcinoma cell lines. Cancer Res., 47:3757-3762,1987.
16. Hubbard, W. C., Alley, M. C., McLemore, T. L., and Boyd, M. R. Evidence for thromboxane biosynthesis in a human lung adenocarcinoma cell line, A549. Fed. Proc., 46:692,1987.
17. Hubbard, W. C., Alley, M. C., McLemore, T. L., and Boyd, M. R. Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas. Cancer Res., in press, 1988.
18. Bakhte, Y. S., and Vane, J. R. Pharmacokinetic function of the pulmonary circulation. Physiol. Rev., 54:1007-1045,1974.
19. Samuelsson, B., Granstrom, E., Green, K., Hamberg, M., and Hammarstrom, S. Prostaglandins. Annu. Rev. Biochem., 44:669-695,1975.
20. Samuelsson, B., Goldyne, M., Granstrom, E., Hamberg, M., Hammarstrom, S., and Malmsten, C. Prostaglandins and thromboxanes. Annu. Rev. Biochem., 47:997-1029, 1978.
21. Vatanabe, K., Iguchi, Y., Iguchi, S., Arai, Y., Hayaishi, O., and Roberts, L. J., II. Stereospecific conversion of prostaglandin D2 to (SZ,13£H155 9a,ll/9,l5-trihydroxyprosta-5,13-dien-l-oic acid (9«, 11 /3-prostaglandin F2) and of prostaglandin H2 to prostaglandin F24, by bovine lung prostaglandin F synthase. Proc. Natl. Acad. Sci. USA, 83: 1583-1587, 1986.
22. Powell, W. S., and Solomon, S. Formation of 20-hydroxyprostaglandins by lungs of pregnant rabbits. J. Biol. Chem. 263:4609-4616,1978.
23. Powell, W. S. Distribution of prostaglandin u-hydroxylases in different tissues. Prostaglandins, 19: 701-710,1980.
24. Honn, K. V., Bockman, R. S., and Marnett, L. J. Prostaglandins and cancer. A review of tumor initiation through tumor metastatis. Prostaglandins, 21: 833–850, 1981.
25. Honn, K. V. In: T. J. Powles, R. S. Bockman, K. V. Honn, and P. Ramwell (eds.). Prostaglandins and Cancer First International Conference, Vol. 2, pp. 733–751. New York: Alan R. Liss, 1982.
26. Rolland, P. H„ Martin, P. M., Jacquemier, J., Rolland, A. M., and Toga, M. Prostaglandins in human breast cancer: evidence suggesting that elevated prostaglandin production is a marker of metastatic potential for neoplastic cells. J. Natl. Cancer Inst., 64:1061-1070,1980.
27. Bresnick, E., Meunier, P., and Lamden, M. Epidermal prostaglandins after topical application of a tumor promoter. Cancer Lett., 7; 121–124, 1979.
28. Verma, A., Ashendel, C. L., and Boutwell, R. K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-0-tetradecanoyl-phorbol- 13-acetate. Cancer Res., 40:308-312, 1980.
29. Levine, L. Arachidonic acid transformation and tumor production. Adv. Cancer Res., 35:49-52, 1981.
30. Fisher, S. M., Mills, G. D., and Slaga, T. J. Inhibition of mouse skin tumor promotion by several inhibitors of arachidonic acid metabolism. Carcinogenesis (Lond.), 3:1243-1250, 1982.
31. Levine, L. Stimulation of cellular prostaglandin production by phorbol esters and growth factors and inhibition by cancer chemopreventive agents. In: T. J. Powles, R. S. Bockmann, K. V. Honn, and P. W. Ramwell (eds.), Prostaglandins and Related Lipids, Vol. 2, pp. 189–205. New York: Alan R. Liss, 1984.
32. Furstenberger, G., Gross, M., and Marks, F. On the role of prostaglandins in the induction of epidermal proliferation, hyperplasia and tumor promotion in mouse skin. In: T. J. Powles, R. S. Bockman, K. V. Honn, and P. W. Ramwell (eds.), Prostaglandins and Related Lipids, Vol. 2, pp. 239–251. New York: Alan R. Liss, 1984.
33. Fischer, S. M., and Slaga, T. J. Modulation of prostaglandin synthesis and tumor promotion. In: T. J. Powles, R. S. Bockmann, K. V. Honn, and P. W. Ramwell (eds.), Prostaglandins and Related Lipids, Vol. 2, pp. 255–261. New York: Alan R. Liss, 1984.
34. Fischer, S. M. Arachidonate cascade and skin tumor promotion. In: H. Thaler-Dao, A. Crastes de Paulet, and R. Paoletti (eds.), Icosanoids and Cancer, pp. 79–90. New York: Raven Press, 1984.
35. Furstenberger, G., Gross, M., and Marks, F. Involvement of prostaglandins in the process of skin tumor promotion. In: H. Thaler-Dao, A. Crastes de Paulet, and R. Paoletti (eds.), Icosanoids and Cancer, pp. 91–100. New York: Raven Press, 1984.
36. Kato, R., Nakadate, T., and Yamamoto, S. Involvement of lipoxygenase products of arachidonic acid in tumor promoting activity of TPS. In: H. Thaler-Dao, A. Crastes de Paulet, and R. Paoletti (eds.), Icosanoids and Cancer, pp. 101–114. New York: Raven Press, 1984.
37. Levine, L., Goldstein, S. M., Snoek, G. T., and Rigas, A. Arachidonic acid metabolism by cells in culture: effect of tumor promoters. In: H. Thaler-Dao, A. Crastes de Paulet, and R. Paoletti (eds.), Icosanoids and Cancer, pp. 115–121. New York: Raven Press, 1984.
38. Sydney, E. and Salmon, M. D. Interrelationship of endogenous macrophages, prostaglandin synthesis and tumor cell clonogenicity in human tumor biopsies. In: T. Powles, T. J. Bockman, K. V. Honn, and P. Ramwell (eds.), Prostaglandins and Cancer First International Conference, pp. 633–651. New York: Alan R. Liss, 1984.
39. Meerpohl, H. G., Bauknecht, T., Tritschler, V., and Lang, H. The influence of prostaglandin E2 on macrophage mediated cytotoxicity. In: W. Forster (ed.), International Workshop: Heterogeneity of Mononuclear Phagocytes, pp. 428–461. New York: Academic Press, 1981.
40. Walker, C., Kristensen, F., Bettens, F., and DeWeck, A. L. Lymphokine regulation of activated (Gi) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin-2 production. J. Immunol., 130:1770-1778, 1983.
41. Young, M. R., and Henderson, S. Enhancement in immunity of tumor bearing time by immunization against prostaglandin E2. luminimi. Commun., 11: 345-352. 1982.